Hypercatabolism of the Third Component of Complement (C3) in Angioimmunoblastic Lymphadenopathy

2009 ◽  
Vol 20 (5) ◽  
pp. 394-398
Author(s):  
P. Teisberg ◽  
I. Åkesson ◽  
S. Halvorsen ◽  
F. Skjørten ◽  
L. Brinch
1974 ◽  
Vol 8 (4) ◽  
pp. 421-421
Author(s):  
Jerry A Winkelstein ◽  
Mary Ruth Smith ◽  
Hyun S Shin ◽  
David H Carver

1972 ◽  
Vol 15 (1) ◽  
pp. 49-56 ◽  
Author(s):  
Arthur Weinstein ◽  
Keith Peters ◽  
David Brown ◽  
Rodney Bluestone

1972 ◽  
Vol 17 (1) ◽  
pp. 85-87 ◽  
Author(s):  
H. W. Goedde ◽  
L. Hirth ◽  
H. -G. Benkmann ◽  
S. Singh ◽  
G. G. Wendt

1986 ◽  
Vol 239 (3) ◽  
pp. 711-716 ◽  
Author(s):  
S Bengio ◽  
D Gilbert ◽  
P Peulve ◽  
M Daveau ◽  
M Fontaine

Phorbol myristate acetate (PMA)-stimulated human monocyte-like cells (U-937) were found to synthesize the third component of complement (C3), as shown by enzyme-linked immunosorbent assay and immunoprecipitation from [35S]methionine-labelled culture supernatants. C3 synthesis occurred at a rate of about 160 ng of C3/24 h per 10(6) cells on day 7 after addition of PMA; it was blocked by cycloheximide treatment and was restored after removal of the inhibitor. SDS/polyacrylamide-gel-electrophoretic analysis of the immunoprecipitated protein showed that the size and subunit structure of the newly synthesized C3 were identical with those of plasma C3, and that a single-chain intracellular precursor was present in the cell lysates. Haemolytic assays showed that the synthesized C3 fully expressed functional activity in early culture within 4 h. After longer culture, a loss of haemolytic activity was observed. The possibility that newly secreted C3 is cleaved by U-937 cells themselves was suggested.


1998 ◽  
Vol 35 (6-7) ◽  
pp. 372 ◽  
Author(s):  
Katia Del Rio-Tsonis ◽  
Panagiotis A. Tsonis ◽  
Ioannis K. Zarkadis ◽  
Andreas G. Tsangas ◽  
John D. Lambris

Sign in / Sign up

Export Citation Format

Share Document